Page 2 - ஜெஃப் காஸ்டெல்லி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெஃப் காஸ்டெல்லி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெஃப் காஸ்டெல்லி Today - Breaking & Trending Today

Amicus Therapeutics Inc (FOLD) Q4 2020 Earnings Call Transcript

Amicus Therapeutics Inc (FOLD) Q4 2020 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Andrew Faughnan , Mitchell Goldman , Jim Wilson , Henri Termeer , Jeff Castelli , Rossella Passero , Bradley Campbell , Johnf Crowley , John Crowley , Daphne Quimi , Exchange Commission , Development Officer , European Union , University Of Pennsylvania , Clinical Research , Amicus Therapeutics Inc , Amicus Therapeutics Fourth Quarter , Year Results Conference Call , Amicus Therapeutic , Chief Executive Officer , Chief Operating Officer , Chief Financial Officer , Chief Development , Chief Science Officer , Senior Vice President , Private Securities Litigation Reform Act ,

Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene .
Amicus Therapeutics, Inc.February 8, 2021 GMT
Initial Data Suggest Early Signs of Disease Stabilization in Children with
Fatal Neurologic Disease
Plan to Submit IND for Next Clinical Study in 2H2021
PHILADELPHIA, Feb. 08, 2021 (GLOBE NEWSWIRE) Amicus Therapeutics (Nasdaq: FOLD) today announced positive initial results from its first in-human study of its CLN3 Batten disease gene therapy program, AT-GTX-502. The results are featured in a virtual poster presentation at the 17th Annual WORLD
Symposium ™ 2021, being held February 8-12, 2021. The poster is also available in the Events and Presentations section of the Amicus Therapeutics corporate website. ....

United States , Andrew Faughnan , Los Reyes , Diana Moore , Jeff Castelli , Amicus Therapeutics , Abigail Wexner Research Institute , Drug Administration , Head Of Global Corporate Communications , Ohio State University College Of Medicine , Initial Data Suggest Early Signs , Disease Stabilization , Fatal Neurologic , Next Clinical Study , Nationwide Children , Unified Batten Disease Rating Scale , Data Highlights , Batten Disease Rating Scale , Chief Development Officer , Principal Investigator , Clinical Pediatrics , Ohio State University College , Fast Track Designation , Rare Pediatric Designation , United States Food , Orphan Drug ,